References
1. Гестационный сахарный диабет: диагностика, лечение, послеродовое наблюдение: клинические рекомендации (протокол лечения) (утверждены Министерством здравоохранения Российской Федерации). 2013. (in Russian)
2. Standards of medical care in diabetes - 2016: summary of revisions. Diabetes Care. 2016; 39: 4-5.
3. Committee on Practice Bulletins - Obstetrics. Practice Bulletin No. 137: Gestational diabetes mellitus. Obstet Gynecol. 2016; 122 (1): 406-16.
4. Ovesen P.G., Jensen D.M., Damm P., et al. Maternal and neonatal outcomes in pregnancies complicated by gestational diabetes. A nation-wide study. J Matern Fetal Neonatal Med. 2015; 28 (14): 1720-4.
5. Bellamy L., Casas J.P., Hingorani A.D., Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet. 2017; 373 (9677): 1773-9.
6. Tobias D.K., Stuart J.J., Li S., et al. Association of history of gestational diabetes with long-term cardiovascular disease risk in a large prospective cohort of US women. JAMA Intern Med. 2017; 177 (12): 1735-42.
7. Fraser A., Lawlor D.A. Long-term health outcomes in offspring born to women with diabetes in pregnancy. Curr Diabetes Rep. 2017; 17 (5): 489.
8. Clausen T.D., Mathiesen E.R., Hansen T., Pedersen O., et al. High prevalence of type 2 diabetes and pre-diabetes in adult offspring of women with gestational diabetes mellitus or type 1 diabetes: the role of intrauterine hyperglycemia. Diabetes Care. 2018; 31 (2): 340-6.
9. Plows J.F., Stanley J.L., Baker P.N., et al. The pathophysiology of gestational diabetes mellitus. Int J Mol Sci. 2018; 19 (11): E3342.
10. Farrar D., Duley L., Medley N., Lawlor D.A. Different strategies for diagnosing gestational diabetes to improve maternal and infant health. Cochrane Database Syst Rev. 2015; 1: CD007122.
11. Caissutti C., Berghella V. Scientific evidence for different options for GDM screening and management: controversies and review of the literature. Biomed Res Int. 2017; 2017: 27 464-71.
12. Hod M., Kapur A., Sacks D.A., Hadar E., et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care. Int J Gynaecol Obstet. 2015; 131 (3): 173-211.
13. The HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes. 2009; 58 (2): 453-9.
14. ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus. Obstet Gynecol. 2018; 131 (2): e49-64.
15. National Institute for Health and Care Excellence (Gran Bretana). Diabetes in Pregnancy: Management from Preconception to the Postnatal Period. London: National Institute for Health and Care Excellence, 2015.
16. Hartling L. Screening and diagnosing gestational diabetes mellitus. Evid Rep Technol Assess. 2012; 210: 1-327.
17. Duran A., Saenz S., Torrejon M.J., Bordiu E., et al. Introduction of IADPSG criteria for the screening and diagnosis of gestational diabetes mellitus results in improved pregnancy outcomes at a lower cost in a large cohort of pregnant women: the St Carlos Gestational Diabetes Study. Diabetes Care. 2014; 37 (9): 2442-50.
18. Brown F.M., Wyckoff J. Application of one-step IADPSG versus two-step diagnostic criteria for gestational diabetes in the real world: impact on health services, clinical care, and outcomes. Curr Diabetes Rep. 2017; 17 (10): 85.
19. Mission J.F., Ohno M.S., Cheng Y.W., Caughey A.B. Gestational diabetes screening with the new IADPSG guidelines: a cost-effectiveness analysis. Am J Obstet Gynecol. 2012; 207 (4): 326.e1-9.
20. Werner E.F., Pettker C.M., Zuckerwise L., et al. Screening for gestational diabetes mellitus: are the criteria proposed by the International Association of the Diabetes and Pregnancy Study Groups Cost-Effective? Diabetes Care. 2012; 35 (3): 529-35.
21. Agarwal M.M., Dhatt G.S., Othman Y. Gestational diabetes: differences between the current international diagnostic criteria and implications of switching to IADPSG. J Diabetes Complications. 2015; 29 (4): 544-9.
22. Scifres C.M., Abebe K.Z., Jones K.A., et al. Gestational Diabetes Diagnostic Methods (GD2M) Study: Comparison of Two Screening Strategies for Gestational Diabetes. URL: clinicaltrials.gov/ct2/show/ (date of access November 25, 2016)
23. Brown J., Grzeskowiak L., Williamson K. et al. Insulin for the treatment of women with gestational diabetes. Cochrane Database Syst Rev. 2016; 1: CD012037.
24. McIntyre H.D., Sacks D.A., Barbour L.A., et al. Issues with the diagnosis and classification of hyperglycemia in early pregnancy. Diabetes Care. 2016; 39: 53-4.
25. Tieu J., McPhee A.J., Crowther C.A., et al. Screening for gestational diabetes mellitus based on different risk profiles and settings for improving maternal and infant health. Cochrane Database Syst Rev. 2017; 8: CD007222.
26. Sweeting A.N., Wong J., Appelblom H., et al. A novel early pregnancy risk prediction model for gestational diabetes mellitus. Fetal Diagn Ther. 2019; 45 (2): 76-84.
27. Zhu W., Yang H., Yan J., et al. Evaluation of the value of fasting plasma glucose in the first prenatal visit to diagnose gestational diabetes mellitus in China. Diabetes Care. 2013; 36 (3): 586-90.28. Yeral M.I., Ozgu-Erdinc A.S., Uygur D., et al. Prediction of gestational diabetes mellitus in the first trimester, comparison of fasting plasma glucose, two-step and one-step methods: a prospective randomized controlled trial. Endocrine. 2014; 46 (3): 512-8.
29. Khalafallah A., Phuah E., Al-Barazan A.M., et al. Glycosylated haemoglobin for screening and diagnosis of gestational diabetes mellitus. BMJ Open. 2016; 6 (4): e011059.
30. Sweeting A.N., Ross G.P., Hyett J. Baseline HbA1c to identify high-risk gestational diabetes: utility in early vs standard gestational diabetes. J Clin Endocrinol Metab. 2017; 102 (1): 150-6.
31. Renz P.B., Chume F.C., Timm J.R.T. Diagnostic accuracy of glycated hemoglobin for gestational diabetes mellitus: a systematic review and meta-analysis. Clin Chem Lab Med. 2019; 57 (10): 1435-49.
32. DePaoli A.M. 20 years of leptin: leptin in common obesity and associated disorders of metabolism. J Endocrinol. 2014; 223 (1): T71-81.
33. Кузнецова Л.А., Шпаков А.О. Адипокины и их возможная роль в ожирении и сахарном диабете 2-го типа (обзор). Saratovskiy nauchno-meditsinskiy zhurnal [Saratov Journal of Medical Scientific Research]. 2018; 14 (2): 201-6. (in Russian)
34. Lawler H.M., Underkofler C.M., Kern P.A., et al. Adipose tissue hypoxia, inflammation, and fibrosis in obese insulin-sensitive and obese insulin-resistant subjects. J Clin Endocrinol Metab. 2016; 101 (4): 1422-8.
35. de Gennaro G., Palla G., Battini L., Simoncini T., et al. The role of adipokines in the pathogenesis of gestational diabetes mellitus. Gynecol Endocrinol. 2019; 35:
36. Bao W., Baecker A., Song Y., et al. Adipokine levels during the first or early second trimester of pregnancy and subsequent risk of gestational diabetes mellitus: a systematic review. Metabolism. 2015; 64 (6): 756-64.
37. Pan B.L., Ma R.M. Correlation of serum omentin-1 and chemerin with gestational diabetes mellitus. Nan Fang Yi Ke Da Xue Xue Bao. 2016; 36 (9): 1231-6.
38. Ashabi A., Sadeghi M., Arab A., Hajianfar H. The association between omentin and diabetes: a systematic review and meta-analysis of observational studies. Diabetes Metab Syndr Obes. 2019; 12: 1277-86.
39. Abell S.K., Shorakae S., Harrison C.L., et al. The association between dys-regulated adipocytokines in early pregnancy and development of gestational diabetes. Diabetes Metab Res Rev. 2017; 33 (8): e2926.
40. Bellos I., Fitrou G., Pergialiotis V., et al. Serum levels of adipokines in gestational diabetes: a systematic review. J Endocrinol Invest. 2019; 42 (6): 621-31.